Reviewing Growlife (PHOT) & Its Competitors

Profitability

This table compares Growlife and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Growlife	N/A	N/A	N/A
Growlife Competitors	-5.54%	0.65%	0.04%

Volatility & Risk

Growlife has a beta of 2.3, meaning that its share price is 130% more volatile than the S&P 500. Comparatively, Growlife’s rivals have a beta of 1.22, meaning that their average share price is 22% more volatile than the S&P 500.

Valuation & Earnings

This table compares Growlife and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Growlife	N/A	-$4.48 million	0.00
Growlife Competitors	$2.83 billion	$80.45 million	-5.59

Growlife’s rivals have higher revenue and earnings than Growlife. Growlife is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

40.3% of shares of all “CONSM PD – MISC DIS” companies are owned by institutional investors. 2.8% of Growlife shares are owned by company insiders. Comparatively, 21.4% of shares of all “CONSM PD – MISC DIS” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Growlife rivals beat Growlife on 6 of the 9 factors compared.

About Growlife

GrowLife, Inc. focuses on the functional mushroom business. It processes, stores, markets, distributes, and sells fresh and dried mushroom products. The company was founded in 2012 and is headquartered in Kirkland, Washington.